DK1229936T3 - Anvendelse af anti-idiotypiske antistoffer som vacciner mod cancer - Google Patents

Anvendelse af anti-idiotypiske antistoffer som vacciner mod cancer

Info

Publication number
DK1229936T3
DK1229936T3 DK00987250T DK00987250T DK1229936T3 DK 1229936 T3 DK1229936 T3 DK 1229936T3 DK 00987250 T DK00987250 T DK 00987250T DK 00987250 T DK00987250 T DK 00987250T DK 1229936 T3 DK1229936 T3 DK 1229936T3
Authority
DK
Denmark
Prior art keywords
against cancer
idiotypic antibodies
vaccines against
vaccines
idiotypic
Prior art date
Application number
DK00987250T
Other languages
Danish (da)
English (en)
Inventor
Hans Loibner
Helmut Eckert
Gottfried Himmler
Original Assignee
Igeneon Krebs Immuntherapie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs Immuntherapie filed Critical Igeneon Krebs Immuntherapie
Application granted granted Critical
Publication of DK1229936T3 publication Critical patent/DK1229936T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00987250T 1999-11-16 2000-11-15 Anvendelse af anti-idiotypiske antistoffer som vacciner mod cancer DK1229936T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0192799A AT409086B (de) 1999-11-16 1999-11-16 Neue verwendung von antikörpern als impfstoffe

Publications (1)

Publication Number Publication Date
DK1229936T3 true DK1229936T3 (da) 2004-08-30

Family

ID=3524036

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00987250T DK1229936T3 (da) 1999-11-16 2000-11-15 Anvendelse af anti-idiotypiske antistoffer som vacciner mod cancer

Country Status (24)

Country Link
EP (1) EP1229936B1 (tr)
JP (1) JP2003514028A (tr)
KR (1) KR20020060968A (tr)
CN (1) CN1390138A (tr)
AT (1) AT409086B (tr)
AU (1) AU780853B2 (tr)
BR (1) BR0015597A (tr)
CA (1) CA2391927A1 (tr)
CZ (1) CZ20021707A3 (tr)
DE (1) DE50006526D1 (tr)
DK (1) DK1229936T3 (tr)
EE (1) EE200200252A (tr)
ES (1) ES2218272T3 (tr)
HU (1) HUP0204216A2 (tr)
IL (1) IL149614A0 (tr)
IS (1) IS6381A (tr)
MX (1) MXPA02004942A (tr)
NO (1) NO20022333L (tr)
NZ (1) NZ518669A (tr)
PL (1) PL356770A1 (tr)
PT (1) PT1229936E (tr)
SK (1) SK6542002A3 (tr)
TR (1) TR200401267T4 (tr)
WO (1) WO2001035989A2 (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017108A (en) * 1975-04-17 1977-04-12 Archibald Kenrick And Sons Limited Window stay
US6294171B2 (en) * 1999-09-14 2001-09-25 Milkhaus Laboratory, Inc. Methods for treating disease states comprising administration of low levels of antibodies
AT410172B (de) * 2000-03-21 2003-02-25 Igeneon Gmbh Verfahren zur herstellung einer vakzineformulierung
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
AT502293B1 (de) * 2002-05-15 2008-03-15 Igeneon Krebs Immuntherapie Immunogener, monoklonaler antikörper
AT500648B1 (de) * 2002-08-12 2010-03-15 Igeneon Krebs Immuntherapie Set zur behandlung von krebspatienten
KR100522526B1 (ko) * 2002-11-28 2005-10-19 주식회사 바이넥스 면역 치료용 수지상 세포의 제조방법
AT500650B1 (de) 2003-04-17 2009-11-15 Altropus Gmbh Immunogener rekombinanter antikörper
WO2007024825A2 (en) * 2005-08-26 2007-03-01 Genway Biotech, Inc. Immunoaffinity separation and analysis compositions and methods
EP2044949A1 (en) 2007-10-05 2009-04-08 Immutep Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
GB201322626D0 (en) 2013-12-19 2014-02-05 Immutep S A Combined preparations for the treatment of cancer
US20180008702A1 (en) * 2014-12-05 2018-01-11 Celltrion Inc. Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same
GB201500374D0 (en) 2015-01-09 2015-02-25 Immutep S A Combined preparations for the treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002848A1 (en) * 1983-01-28 1984-08-02 Centocor Inc Anti-idiotypic antibodies to t cell antigen receptors
NZ229159A (en) * 1988-05-17 1992-11-25 Soldano Ferrone Anti-idiotype antibodies which bind to the idiotype of murine antibody 225.28
US20030072751A1 (en) * 1990-03-14 2003-04-17 Heribert Bohlen Idiotypic vaccination against b cell lymphoma
IT1254315B (it) * 1992-03-27 1995-09-14 Mini Ricerca Scient Tecnolog Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.
CA2139756A1 (en) * 1992-07-08 1994-01-20 Eric M. Bonnem Use of gm-csf as a vaccine adjuvant
AU704829B2 (en) * 1994-12-28 1999-05-06 University Of Kentucky Murine anti-idiotype antibody 3H1

Also Published As

Publication number Publication date
EP1229936A2 (de) 2002-08-14
NO20022333L (no) 2002-06-03
CZ20021707A3 (cs) 2002-10-16
TR200401267T4 (tr) 2004-07-21
MXPA02004942A (es) 2003-10-14
EP1229936B1 (de) 2004-05-19
CN1390138A (zh) 2003-01-08
AU2357201A (en) 2001-05-30
PL356770A1 (en) 2004-07-12
NO20022333D0 (no) 2002-05-15
ATA192799A (de) 2001-10-15
CA2391927A1 (en) 2001-05-25
SK6542002A3 (en) 2002-11-06
ES2218272T3 (es) 2004-11-16
NZ518669A (en) 2003-08-29
IL149614A0 (en) 2002-11-10
EE200200252A (et) 2003-06-16
PT1229936E (pt) 2004-09-30
HUP0204216A2 (en) 2003-04-28
KR20020060968A (ko) 2002-07-19
IS6381A (is) 2002-05-14
BR0015597A (pt) 2002-07-23
AU780853B2 (en) 2005-04-21
WO2001035989A2 (de) 2001-05-25
WO2001035989A3 (de) 2001-10-04
DE50006526D1 (de) 2004-06-24
JP2003514028A (ja) 2003-04-15
AT409086B (de) 2002-05-27

Similar Documents

Publication Publication Date Title
PT1210113E (pt) Composicoes de vacinas de combinacao
DE60045324D1 (de) Impfstoffzusammensetzung
NO20014323D0 (no) Vaksine
DK1326638T3 (da) Vacciner mod cancer
DE50007817D1 (de) Mikrospiegel
DE60020617D1 (de) Zementierkopf
DK1390066T3 (da) Vaccinesammensætning
DE60033715D1 (de) Servo-Regler
DK1139764T3 (da) Adjuvanssammensætning
DE60002650D1 (de) Öladjuvierter Impfstoff
NO20020763D0 (no) Vaksine
DK1176964T3 (da) Brug af ET743 til behandling af cancer
ITMI991658A0 (it) Procedimento per la preparazione di epossidi
DK1229936T3 (da) Anvendelse af anti-idiotypiske antistoffer som vacciner mod cancer
DE60043058D1 (de) Dentalwerkstoffe
DK1350521T3 (da) Immunoterapeutiske kombinationer til behandling af tumorer
DE60129876D1 (de) Optischer Tomograph
DK1311267T3 (da) Retroviral immunoterapi
DE60044696D1 (de) Lippenstift
DK1180041T4 (da) Vaccine mod ISA-virus
DE10294532D2 (de) Künstlicher Lymphknoten
DE60004330D1 (de) Zentrifugalzerstäuber
DK199900092U3 (da) Flisebelægning
SE9904109D0 (sv) Kosmetisk beredning
FI4183U1 (fi) Patja